December 10, 2019
Ad Scientiam and Biogen announce a scientific collaboration to develop innovative digital solutions for clinical research in neuroscience, building on the experience of MSCopilot®.
Ad Scientiam and Biogen announce a scientific collaboration to develop innovative digital solutions for clinical research in neuroscience.
This collaboration builds on Ad Scientiam's successful experience with MSCopilot®, its software medical device, and on Biogen's commitment to innovative scientific research to overcome devastating neurological diseases.